rm features a proprietary platinum chromium alloy, designed specifically for coronary stents. This alloy, coupled with a new stent architecture, is designed to allow thinner struts, increased flexibility and a lower profile, while improving radial strength, recoil and visibility. In addition, all three Element Stents incorporate the new Apex(TM) Dilatation Catheter technology, designed to enhance deliverability.
"We are pleased to bring the next-generation Element drug-eluting stent platform another step closer to commercialization," said Hank Kucheman, Senior Vice President and Group President, Cardiovascular for Boston Scientific. "We are confident that the next-generation Element platform - to be offered in everolimus, paclitaxel and bare-metal versions - will further extend our global drug-eluting stent leadership."
The PROMUS Element, TAXUS Element and bare-metal Element Stents are investigational devices and are limited by applicable law to investigational use only and are not available for sale.
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance
Page: 1 2 3 4 Related biology technology :1
|SOURCE Boston Scientific Corporation|
Copyright©2009 PR Newswire.
All rights reserved
. Boston Scientifics Urology/Gynecology Business Forms Marketing Alliance with Bladder Health Network2
. Boston Scientific Statement on the Passing of Senator Edward Kennedy3
. Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT-CRT Trial4
. Boston University Periodontal Study on Imagenetix Compound Published in The Journal of Periodontology5
. Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System6
. Boston Scientific to Participate in Wachovia Conference7
. Boston Scientifics SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R)8
. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System9
. FDA Approves Boston Scientifics Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System10
. Angiotechs corporate partner, Boston Scientific, announces launch of third-generation TAXUS(R) Element(TM) Stent11
. Boston Scientific Welcomes Launch of Syntax Score Website